Benjamin Rolland

Summary

Affiliation: CHRU de Lille
Country: France

Publications

  1. doi Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individuals
    Benjamin Rolland
    PRES Nord de France and Department of Psychiatry, Paediatric Psychiatry and Addiction Medicine, CHU Lille, Lille, France
    Clin Neuropharmacol 36:98-9. 2013
  2. doi [Abstinence in alcohol-dependence: critical and updated approach of the 2001 national guidelines]
    Benjamin Rolland
    CHU Lille, Service d Addictologie, 59037 Lille, France
    Presse Med 42:19-25. 2013
  3. doi A case of de novo seizures following a probable interaction of high-dose baclofen with alcohol
    Benjamin Rolland
    Department of Addiction Medicine, CHU Lille, Hopital Calmette, Av du Pr Leclercq, F 59037 Lille, France
    Alcohol Alcohol 47:577-80. 2012
  4. ncbi Pharmaceutical approaches of binge drinking
    Benjamin Rolland
    Univ Lille Nord de France, F 59000 Lille, France
    Curr Pharm Des 17:1333-42. 2011
  5. doi Shared vulnerability between seizures and psychosis in cocaine addiction?
    Benjamin Rolland
    Universite Lille Nord de France, Lille, France
    Epilepsy Behav 22:596-8. 2011
  6. ncbi [A system of prescriptions without drug approval: example of baclofen]
    Benjamin Rolland
    Service d Addictologie, Universite Lille Nord de France, CHRU, Lille, France
    Therapie 65:511-8. 2010
  7. doi Early relapse in alcohol dependence may result from late withdrawal symptoms
    Nicolas Simioni
    Department of Addiction Medicine, CHU Lille, Lille, France
    Med Hypotheses 79:894-5. 2012
  8. doi Catatonia and alcohol withdrawal: a complex and underestimated syndrome
    Pierre Alexis Geoffroy
    Univ Lille Nord de France, France
    Alcohol Alcohol 47:288-90. 2012
  9. doi Are gait initiation parameters early markers of Huntington's disease in pre-manifest mutation carriers?
    Arnaud Delval
    Department of Neurology, Regional University Hospital, F 59037 Lille Cedex, France
    Gait Posture 34:202-7. 2011
  10. doi Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder
    Benjamin Rolland
    From the PRES Nord de France, Univ Lille Nord de France and Departmentsof Psychiatry and Addiction Medicine, Pharmacology and Pharmacovigilance, and Resuscitation Care, CHU Lille, Lille, France
    J Clin Psychopharmacol 34:153-6. 2014

Collaborators

Detail Information

Publications14

  1. doi Aripiprazole for treating cannabis-induced psychotic symptoms in ultrahigh-risk individuals
    Benjamin Rolland
    PRES Nord de France and Department of Psychiatry, Paediatric Psychiatry and Addiction Medicine, CHU Lille, Lille, France
    Clin Neuropharmacol 36:98-9. 2013
    ..Treating CIPSs in ultrahigh risk individuals who cannot stop or refuse stopping cannabis might fit a harm-reduction strategy by preventing transition into psychosis...
  2. doi [Abstinence in alcohol-dependence: critical and updated approach of the 2001 national guidelines]
    Benjamin Rolland
    CHU Lille, Service d Addictologie, 59037 Lille, France
    Presse Med 42:19-25. 2013
    ..Better knowledge about these subgroups of patients could allow the diversifying and personalising of care schemes, including in some cases temporary abstinence or controlled-drinking patterns...
  3. doi A case of de novo seizures following a probable interaction of high-dose baclofen with alcohol
    Benjamin Rolland
    Department of Addiction Medicine, CHU Lille, Hopital Calmette, Av du Pr Leclercq, F 59037 Lille, France
    Alcohol Alcohol 47:577-80. 2012
    ..Although baclofen is considered to be quite safe at low doses, the possible interactions between HDB and alcohol have not been precisely studied...
  4. ncbi Pharmaceutical approaches of binge drinking
    Benjamin Rolland
    Univ Lille Nord de France, F 59000 Lille, France
    Curr Pharm Des 17:1333-42. 2011
    ..Furthermore, these schemes also mention harm-reductive neuroprotective and hepatoprotective strategies, which could be included in the arsenal of possible medications for BD in the near future...
  5. doi Shared vulnerability between seizures and psychosis in cocaine addiction?
    Benjamin Rolland
    Universite Lille Nord de France, Lille, France
    Epilepsy Behav 22:596-8. 2011
    ....
  6. ncbi [A system of prescriptions without drug approval: example of baclofen]
    Benjamin Rolland
    Service d Addictologie, Universite Lille Nord de France, CHRU, Lille, France
    Therapie 65:511-8. 2010
    ..If this proves to be successful with baclofen, it is possible to extend the use of CAMTEA to other drugs without AMM approval in addictologic pathologies...
  7. doi Early relapse in alcohol dependence may result from late withdrawal symptoms
    Nicolas Simioni
    Department of Addiction Medicine, CHU Lille, Lille, France
    Med Hypotheses 79:894-5. 2012
    ..Thus, we hypothesize that early relapses are more the consequence of late symptoms of PD than AA. From this standpoint, we propose that prolonged treatment with benzodiazepines may reduce the first-month relapse rate...
  8. doi Catatonia and alcohol withdrawal: a complex and underestimated syndrome
    Pierre Alexis Geoffroy
    Univ Lille Nord de France, France
    Alcohol Alcohol 47:288-90. 2012
    ..We think that this co-occurrence could be underestimated in clinics because alcohol withdrawal symptoms may distract from its identification...
  9. doi Are gait initiation parameters early markers of Huntington's disease in pre-manifest mutation carriers?
    Arnaud Delval
    Department of Neurology, Regional University Hospital, F 59037 Lille Cedex, France
    Gait Posture 34:202-7. 2011
    ..However, two such parameters (stride-to-stride variability and first step duration under ST conditions) already appear to be sufficiently reliable diagnostic tools for differentiating between PMCs and HCs...
  10. doi Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder
    Benjamin Rolland
    From the PRES Nord de France, Univ Lille Nord de France and Departmentsof Psychiatry and Addiction Medicine, Pharmacology and Pharmacovigilance, and Resuscitation Care, CHU Lille, Lille, France
    J Clin Psychopharmacol 34:153-6. 2014
    ..Moreover, further research should investigate to what extent GABA-A and GABA-B induce shared or distinct neuroadaptation processes and withdrawal syndromes. ..
  11. ncbi Therapeutic prospects of PPARs in psychiatric disorders: a comprehensive review
    Benjamin Rolland
    Department of Pharmacology, EA 1046, Univ Lille Nord de France, CHU Lille, Lille, France
    Curr Drug Targets 14:724-32. 2013
    ..At the time of the emerging concept of psychoneuroimmunology, PPARs open original therapeutic prospects for the psychiatric research...
  12. doi [Clinical alcohology]
    Olivier Cottencin
    UDSL, EA4559, 59000 Lille, France
    Presse Med 41:1248-58. 2012
    ..It combines hydration, benzodiazepines and thiamine. Strategies against alcoholism relapse use better evaluated psychotherapies (as behavioral and cognitive therapies) and the development of new pharmacological treatments...
  13. pmc The PPARα Agonist Fenofibrate Reduces Prepulse Inhibition Disruption in a Neurodevelopmental Model of Schizophrenia
    Benjamin Rolland
    Département de Pharmacologie médicale, EA 1046, Universite Lille Nord de France, 1 place de Verdun, 59000 Lille, France
    Schizophr Res Treatment 2012:839853. 2012
    ..We notably found a significant difference (P < 0.05) in PPIm between groups KN and KF at PND56, which supposes that fenofibrate could be worthy of interest for early neuroprotection in schizophrenia...
  14. ncbi GABAergic and glutamatergic modulation in binge eating: therapeutic approach
    Dewi Guardia
    Service d Addictologie CHRU de Lille Hôpital Calmette, Bd du Pr Jules Leclercq, 59037 Lille, France
    Curr Pharm Des 17:1396-409. 2011
    ..Limitations of these studies are discussed. In view of these data, first- and second-line pharmacological interventions are proposed...